Lyra Therapeutics, a venture-backed pharmaceuticals company located in the Boston metro area, is focused on the development of controlled drug delivery products. The company uses materials engineering to bring life-changing therapies to patients. Our multi-disciplinary team of biologists, chemists, materials scientists, engineers and business professionals work in close collaboration to create solutions that address some of today’s most challenging and critical unmet clinical needs. We are a clinical-stage company pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people. Our goal is to transform the ENT treatment paradigm by providing effective front-line solutions for physicians and new treatment options for their patients.